Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Harvard Apparatus Regenerative Technology Days Inventory?
Harvard Apparatus Regenerative TechnologyHRGN 27 Days Inventory is 6.87 as of Mar. 2026, which is 96% below its 10-year median of 161.93. GuruFocus rates HRGN with a GF Score™ of 27/100 and a GF Value™ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,870 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks better than 97.49% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Harvard Apparatus Regenerative Technology's Inventory Turnover for the
three
months ended in Mar. 2026 was 13.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Harvard Apparatus Regenerative Technology's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.07.
Harvard Apparatus Regenerative Technology (OTCPK:HRGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Harvard Apparatus Regenerative Technology's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Harvard Apparatus Regenerative Technology's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Harvard Apparatus Regenerative Technology Days Inventory Related Terms
Harvard Apparatus Regenerative Technology Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology Days Inventory Chart
Harvard Apparatus Regenerative Technology Annual Data
HRGN vs DTEAF, STCB, JVA: Days Inventory Comparison
For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harvard Apparatus Regenerative Technology Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Days Inventory distribution charts can be found below:
* The bar in red indicates where Harvard Apparatus Regenerative Technology's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harvard Apparatus Regenerative Technology (HRGN) has a Days Inventory of 6.87 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Harvard Apparatus Regenerative Technology and its competitors. This is 96% below median its historical median of 161.93. Over the past decade, Harvard Apparatus Regenerative Technology's Days Inventory has ranged from 11.41 to 760.42. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #47 out of 1870 companies in the Consumer Packaged Goods industry, placing it in the top 2.5%.
Is Harvard Apparatus Regenerative Technology's Days Inventory too high?
Harvard Apparatus Regenerative Technology's current Days Inventory of 6.87 is 96% below median its 10-year median of 161.93. Over the past 10 years, this metric has ranged from a low of 11.41 to a high of 760.42. The Consumer Packaged Goods industry median Days Inventory is 82.95. Harvard Apparatus Regenerative Technology's value of 6.87 is 91.7% below this industry median. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #47 out of 1870 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Days Inventory compare to DTEAF and STCB?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #47 out of 1870 companies for Days Inventory. This places Harvard Apparatus Regenerative Technology in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 82.95. Harvard Apparatus Regenerative Technology's value of 6.87 is 91.7% below this benchmark. Historically, Harvard Apparatus Regenerative Technology's own Days Inventory has ranged from 11.41 to 760.42 over the past decade. While the company's 10-year median is 161.93 vs. the industry median of 82.95, Harvard Apparatus Regenerative Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 82.95, based on 1,870 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Harvard Apparatus Regenerative Technology's current Days Inventory of 6.87 is 91.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Harvard Apparatus Regenerative Technology and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 82.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harvard Apparatus Regenerative Technology's current Days Inventory is 6.87, which is 96% below median its own 10-year median of 161.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.05 — trading 80.3% below its estimated fair value. The current Days Inventory is 6.87, which is 96% below median its 10-year median of 161.93 and 91.7% below the Consumer Packaged Goods industry median of 82.95. Harvard Apparatus Regenerative Technology's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Days Inventory is 6.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued.
The current stock price of $1.05 is trading 80.3% below its estimated GF Value™ of $5.34.
GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.
Key valuation signals for HRGN:
Days Inventory: 6.87 (96% below median its 10-year median of 161.93)
GF Value™: $5.34 vs. price of $1.05 (80.3% below fair value)
Industry Position: 91.7% below the Consumer Packaged Goods median (#47 of 1870)
No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harvard Apparatus Regenerative Technology Business Description
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
27GF Score
Get the complete analysis for HRGN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HRGN has been successfully added to your 
